Mark Verratti Insider Trading $MYGN MYRIAD GENETICS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark Verratti.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark Verratti. Mark Verratti is VP Global Sales in CYBERONICS INC ($CYBX) and VP Sales in CYBERONICS INC ($CYBX) and President Assurex Health Inc. in MYRIAD GENETICS INC ($MYGN) and President, Myriad Neuroscience in MYRIAD GENETICS INC ($MYGN).

Mark Verratti in MYRIAD GENETICS INC

Trading Symbol: MYGN
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Mark Verratti: President, Myriad Neuroscience, President Assurex Health Inc.
Holdings: 157,130 shares
Current Value: $2,419,802
Latest Transaction: Mar 26 2021
$MYGN Market Capitalization: $1.13B
$MYGN Previous Close: $15.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark Verratti in MYRIAD GENETICS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CYBX, MYGN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 26 2021MYGNMYRIAD GENETICS IN ...Verratti MarkPresident, Myriad N ...GrantA0.0015,4410157,130141.7 K to 157.1 K (+10.90 %)
Oct 13 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...GrantA0.0031,2580141,689110.4 K to 141.7 K (+28.31 %)
Oct 01 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD13.047259,454110,431111.2 K to 110.4 K (-0.65 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD12.442,37629,557111,156113.5 K to 111.2 K (-2.09 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD12.442,37629,557111,156113.5 K to 111.2 K (-2.09 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD12.442,89736,039113,532116.4 K to 113.5 K (-2.49 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD12.442,89736,039113,532116.4 K to 113.5 K (-2.49 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD12.442,89736,039116,429119.3 K to 116.4 K (-2.43 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD12.442,89736,039116,429119.3 K to 116.4 K (-2.43 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...GrantA0.0032,8000119,32686.5 K to 119.3 K (+37.91 %)
Sep 28 2020MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...GrantA0.0032,8000119,32686.5 K to 119.3 K (+37.91 %)
Oct 01 2019MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD28.6372520,75779,05979.8 K to 79.1 K (-0.91 %)
Sep 26 2019MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD29.932,89786,70779,78482.7 K to 79.8 K (-3.50 %)
Sep 26 2019MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD29.932,89786,70782,68185.6 K to 82.7 K (-3.39 %)
Oct 02 2018MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD46.0072533,35085,57886.3 K to 85.6 K (-0.84 %)
Sep 26 2018MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD46.652,897135,14586,30389.2 K to 86.3 K (-3.25 %)
Sep 21 2018MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...GrantA0.0040,000089,20049.2 K to 89.2 K (+81.30 %)
Oct 03 2017MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...SellD36.1880028,94449,20050 K to 49.2 K (-1.60 %)
Sep 15 2017MYGNMYRIAD GENETICS IN ...Verratti MarkPresident Assurex H ...GrantA0.0040,000050,00010 K to 50 K (+400.00 %)

Page:   1